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Background: Brachycephalic dogs have unique upper respiratory anatomy with abnormal breathing patterns
similar to those in humans with obstructive sleep apnea syndrome (OSAS). The objective of this study was to
evaluate the correlation between anatomical components, clinical signs and several biomarkers, used to determine
systemic inflammation and myocardial damage (C-reactive protein, CRP; Haptoglobin, Hp; cardiac troponin I, cTnI),
in dogs with brachycephalic upper airway obstructive syndrome (BAOS).
Results: Fifty brachycephalic dogs were included in the study and the following information was studied:
signalment, clinical signs, thoracic radiographs, blood work, ECG, components of BAOS, and CRP, Hp and cTnI levels.
A high proportion of dogs with BAOS (88%) had gastrointestinal signs. The prevalence of anatomic components of
BAOS was: elongated soft palate (100%), stenotic nares (96%), everted laryngeal saccules (32%) and tracheal
hypoplasia (29.1%). Increased serum levels of biomarkers were found in a variable proportion of dogs: 14% (7/50)
had values of CRP > 20 mg/L, 22.9% (11/48) had values of Hp > 3 g/L and 47.8% (22/46) had levels of cTnI > 0.05 ng/
dl. Dogs with everted laryngeal saccules had more severe respiratory signs (p<0.02) and higher values of CRP
(p<0.044). No other statistical association between biomarkers levels and severity of clinical signs was found.
Conclusions: According to the low percentage of patients with elevated levels of CRP and Hp, BAOS does not
seem to cause an evident systemic inflammatory status. Some degree of myocardial damage may occur in dogs
with BAOS that can be detected by cTnI concentration.
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Brachycephalic upper airway obstructive syndrome
(BAOS) is a combination of nasal and oropharyngeal
anatomic abnormalities resulting from selective breeding
to reduce the length of the maxilla without concurrent
reduction in the soft tissue of the nose, palate, and phar-
ynx [1,2]. The resulting excess of soft tissue causes air-
way obstruction in affected animals, with clinical signs
that may include inspiratory stertor and stridor, exercise
and heat intolerance, cyanosis, respiratory distress, re-
gurgitation, and vomiting. The primary abnormalities of* Correspondence: marta.planellas@uab.cat
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reproduction in any medium, provided the orBAOS are stenotic nares and an overlong soft palate.
Secondary changes that occur as a result of chronic
upper airway obstruction include eversion of laryngeal
saccules, pharyngeal edema and laryngeal collapse. Bra-
chycephalic dogs can present other respiratory tract ab-
normalities such as tracheal hypoplasia, bronchial
collapse, macroglossia, reduced buccal opening, naso-
pharyngeal collapse and nasopharyngeal turbinates [1-7].
Such dogs have anatomic abnormalities that include
small pharyngeal airways and abnormal breathing pat-
terns similar to those in humans with obstructive sleep
apnea syndrome (OSAS) [8,9]. On the other hand, it
have been reported that the English bulldog has snoring,
fragmented sleep with mild hypoxemia and apneas in
the same manner as human patients with OSAS. Thosel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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suitable natural animal model for human OSAS [8,9].
Inflammation is the characteristic trait of the patho-
physiology of OSAS and represents a pathway linking
human OSAS patients with increased cardiovascular
morbidity [10,11]. C-reactive protein (CRP) levels have
been shown to be high in the presence of hypoxia, for
example at high altitude [12]. Furthermore, CRP may
also increase with sleep deprivation [13]. Both hypox-
emia and sleep deprivation are frequently present in
human patients with OSAS, and therefore may partici-
pate in the genesis of an inflammatory response [13].
Hypoxia also may increase fatigability of upper airway
dilator muscle and soft tissue, in a manner that has the
potential to worsen disease. Inflammation, as well as oxi-
dative stress, resulted from the repeated hypoxia and re-
oxygenations could be implicated in the injury to these
tissues [14,15].
Some epidemiological studies have linked high hapto-
globin (Hp) levels with a greater incidence of myocardial
infarct [16]. Kim and others [16] have reported that
human patients with OSAS have higher levels of Hp,
which fell after medical treatment with a continuous
positive airway pressure device.
Cardiac troponin I (cTnI) and T (cTnT) are definitive
biomarkers for detection of myocardial injury in human
patients [17,18], and more recently in dogs [19,20]. In
dogs with acute myocardial injuries or infarction, the
concentration of cTnI has been shown to be positively
correlated with the size of the infarct [21]. Moreover,
chronic increases in cTnI are associated with chronic or
ongoing pathologic myocardial process [21].
Even though human OSAS is not equal to canine
BAOS, similarities exist. On the other hand, dogs with
BAOS present clinical abnormalities (chronic hypoxia,
gastrointestinal signs and subclinical heatstroke) that
make it worthy to rule out the presence of systemic in-
flammation and myocardial damages.
The objective of this study was to evaluate the correlation
between anatomical components, clinical signs and severalTable 1 Gradation of respiratory and digestive signs in 50 br
Grade of clinical signs Respiratory s
(stertors, sno
inspiratory e
stress, exerci
intolerance,
syncope)
n
Grade 0- Absent 0
Grade 1-Mild Stertors during exercise (<once week) 1
Grade 2-Moderate Continuous stertor (< once daily) 13
Grade 3-Severe Exercice intolerance, cianosis (>once daily) 36biomarkers, used to determine systemic inflammation and
myocardial damage (CRP, Hp, cTnI), in dogs with BAOS.
Results
Epidemiological data
Male dogs were over-represented in the study since 30
males (two neutered) and 20 females (four neutered)
were evaluated. The median age was 2.5 years old (range
1–10 years old). Thirty-eight dogs (76%) were less than
three years old. All were purebred: French bulldogs were
the commonest breed studied and accounted for 29 of
the 50 cases (58%), while other breeds evaluated
included English bulldogs (n = 8, 16%), Pug (n = 12, 24%)
and Shih-tzu (n = 1, 2%).
Clinical signs
All dogs had some kind of respiratory signs (Table 1): only
one dog had a mild grade of respiratory signs (grade 1), 13
(26%) suffered from a moderate grade (grade 2) and 36
(72%) from a severe grade (grade 3). Although a large
number of animals with respiratory signs also had digest-
ive signs (mild or moderate), no correlation was found be-
tween both types of signs (p=0.71).
Electrocardiograms (ECG) were recorded previously to
upper airway (UA) inspection and the presence of
arrhythmia and heart rate was recorded. Three out of fifty
presented sinusal arrhythmia indicating parasympathetic
dominance. Heart rate values ranged from 70 to 180 beats
per minute. No other abnormalities have been observed in
ECG reports.
The inspection of the UA respiratory tracts revealed
abnormalities in all 50 patients: abnormally long and
hyperplasic soft palate (50/50 dogs; 100%), stenotic nares
(48/50 dogs; 96%) and everted laryngeal saccules (16/50
dogs; 32%). Thoracic radiography was performed in 48
cases and tracheal hypoplasia was diagnosed in 14 ani-
mals 29.1% dogs; pug (n = 4), English bulldog (n = 2) and
French bulldog (n = 8)] with a DTI/DT (thoracic inlet to
tracheal diameter) ratio that ranged from 0.08 to 0.3.
Thoracic radiography also allowed us to record vertebralachycephalic dogs suffering from BAOS
igns Grade of clinical signs Digestive signs
ring,
fforts,
se
(regurgitation, vomiting)
% n %
0% Grade 0- Absent 6 12%
2% Grade 1-Mild (< once week) 23 46%
26% Grade 2-Moderate (< once daily) 14 28%
72% Grade 3-Severe (> once daily) 7 14%
Table 3 Statistical analysis showing the association of
different variables with respiratory and digestive signs
Variable Respiratory signs Digestive signs
@ p value @ p value
Age 0.154 0.255 0.052 0.645
Sex - 0.317* 0.026* - 0.162 0.258
Breed 0.197 0.17 - 0.254 0.067
HTC - 0.003 0.990 - 0.131 0.99
WBC - 0.099 0.583 - 0.016 0.916
Platelets 0.008 0.97 - 0.039 0.8
Total Protein 0.347 0.066 0.206 0.28
Ratio DT/DTI - 0.187 0.195 - 0.127 0.38
CRP 0.076 0.581 - 0.063 0.66
Hp - 0.025 0.87 - 0.143 0.33
cTnI 0.261 0.087 0.352* 0.016*
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values from 8.5 to 12.1 [22]. The elevated incidence of
hemivertebra in brachycephalic dogs made the VHS
measurement impossible in 15 dogs.
Laboratory data
Table 2 shows the relationship between CRP, Hp and
cTnI levels in the different breeds. The median CRP
concentration in brachycephalic dogs with BAOS was
7.8 mg/L (3.6-235 mg/L). Seven of the 50 dogs studied
had high concentrations of CRP. Hp levels were mea-
sured in 48 dogs, with a median Hp concentration of
1.6 g/L (range 0.09-13.9 g/L). From those, 11 (22.9%)
had increased Hp levels. The median cTnI value was
0.05 ng/ml (<0.05–0.29), while 47.8% (22/46) of dogs
with BAOS had high values of cTnI (>0.05).
Table 3 shows that there was a significant correlation
between the severity of the respiratory signs and male
patients (p= 0.026).
The present study did not find a significant association
between the severity of respiratory and digestive signs
and CRP, Hp and cTnI levels. However, patients with
everted laryngeal saccules had more severe respiratory
signs (p= 0.02) and higher levels of CRP (p= 0.044). The
presence of tracheal hypoplasia was not associated with
an increased severity of respiratory signs.
There was a significant correlation between the pres-
ence of digestive signs and cTnI (p= 0.016). When the
severity digestive signs was studied in relation to cTnI
levels, it was observed that animals with grade 2 of di-
gestive signs had higher levels of cTnI than animals with
grade 1 (p= 0.026). The possible relation of heart rate
and arrhythmias with CRP, Hp and cTnI was statistically
studied without obtaining any significance. In the same
way, VHS values were not statistically associated with
any biomarker (CRP, Hp and cTnI) or ECG values.
Discussion
To the authors’ knowledge, this is the first prospective
clinical study of dogs suffering from BAOS that has eval-
uated the levels of several biomarkers [acute phase pro-
teins (CRP, Hp) and cTnI] and the relation of them with
clinical signs and anatomical features.Table 2 CRP, Hp and cTnI levels in the different breeds of
the 50 brachycephalic dogs studied
Breed CRP>20 mg/dl Hp>3 g/L cTnI > 0.05 ng/dl
n % n % n %
English B 3/8 37.5 0/8 0 8/8 100
French B 3/29 10.3 5/27 18.5 14/26 53.8
Pug 1/12 8.3 6/12 50 0/11 0
Shitzu 0/1 0 0/1 0 0/1 0
Total 7/50 14 11/48 22.9 22/46 47.8The English bulldog has snoring and fragmented sleep
[23] with mild hypoxemia and apneas only during rapid
eye movement. English bulldog is the closest animal
model for OSAS. Even if, UA obstructive disease in dogs
is not equal to OSAS, important similarities exist. Some
studies used brachycephalic dogs, as an animal model, to
evaluate pharyngeal dilator muscular damages in UA ob-
structive disease, observing similar alterations to human
patients with OSAS [23,24].
The correlation between human OSAS, inflammation
and cardiovascular disease is well established [10,13,16].
The mechanism involved in the development of cardio-
vascular disease is attributed to increased sympathetic
activity due to sleep deprivation and fragmentation, and
repetitive hypoxemic events with significant arterial de-
saturation. These factors are believed to lead to an acti-
vation of pro-inflammatory cytokines. Even if OSAS and
BAOS are different syndromes, this study tries to clear
up a possible association of BAOS, inflammation and
cardiovascular diseases.
The presence of digestive signs in dogs with BAOS has
been described elsewhere [3,25-27]. The relationship be-
tween respiratory and digestive signs is due to the exag-
gerated repetitive variation of diaphragmatic pressure,
present in patients with obstructive breathing, which
causes gastroesophageal reflux and inflammation of the
oropharyngeal areas that, in turn, worsen respiratory
signs [3,27]. Poncet and others [3,27] found an associ-
ation between the severity of respiratory and digestive
signs in dogs with BAOS, which suggests that these signs
are related. These authors also used endoscopy and
histological studies to reveal the presence of lesions in
the digestive tract of all dogs with BAOS. The majority
of dogs with BAOS in the present study had digestive
signs, but no association between the severity of digest-
ive and respiratory signs was found. Even though the
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clear, a correlation with severity of both signs is not al-
ways present. The results of the study indicate a correl-
ation between the presence of digestive signs and high
cTnI values, but authors did not find any plausible ex-
planation for this association. Further studies should be
performed in order to find the physiological reason of
this correlation.
The most common anomalies present in dogs from
the present study were stenotic nares and elongated soft
palate, similar to findings described by previous studies
[16,26,28]. However, the prevalence of everted laryngeal
saccules in dogs of the present study was lower that pre-
viously reported [4,6,29]. Due to the prospective nature
of this study, the presence of tracheal hypoplasia was
evaluated in nearly all the cases included (96%) and was
found in 14 dogs (29.1%). Tracheal hypoplasia is a con-
current finding in many patients with BAOS [1-3,5-
7,25,30]. English bulldogs are more commonly affected
by tracheal hypoplasia than other breeds, which could
have biased our results [1,30,31]. But, according other
studies and our results, in the absence of concurrent
pulmonary disease, tracheal hypoplasia is usually not
associated with clinical signs [31-33]. It may exacerbate
the respiratory signs associated with BAOS because of
increased resistance to airflow, but tracheal hypoplasia,
according our results and other reports, is not associated
with worse outcomes after surgical correction of BAOS
[1,6,31,33,34].
The presence of nasopharyngeal turbinates can be an
important anatomic component of BAOS [4], but in the
present study it has not been evaluated in all dogs due
to the multicentric nature of the study.
The innovative aspects of this work are the determin-
ation of different biomarkers in dogs with BAOS. The
design of the study included a complete work-up to ex-
clude other diseases that might affect the results of bio-
marker determination. In human medicine, high values
of C-reactive protein (CRP) have been found in OSAS
patients and have been associated with the severity of re-
spiratory signs according to the apnea/hypopnea index
[35]. The apnea/hypopnea index, obtained during poli-
somnography, is an important parameter for describing
the severity of OSAS and describes the number of
apneas or hypopneas per hour. Moreover levels of CRP,
Hp and IL-6 in human patients with OSAS decreased
after surgical or medical treatment [16,36]. A study per-
formed with 17 brachycephalic dogs showed that some
proinflammatory cytokines and nitric oxide are increased
in brachycephalic dogs and also correlated with the se-
verity of clinical signs [37]. Even though, in the present
study few dogs had high values of CRP and Hp, and no
correlation with the severity of respiratory signs was
observed, with the exception of patients with evertedlaryngeal saccules. The presence of everted laryngeal sac-
cules is considered a secondary change from airway ob-
struction, but can contribute to aggravate obstructive
upper airway signs. A significant association has been
found between the presence of everted laryngeal, severity
of respiratory signs and CRP levels indicating that the
presence of everted laryngeals can increase upper airway
obstruction leading to severe respiratory signs and in-
crease of inflammatory biomarkers. By contrast, the
present results suggest that CRP and Hp determination,
in general, do not offer valuable information in dogs
with BAOS. Probably, in brachycephalic dogs, BAOS do
not cause such an inflammatory status as OSAS in
human patients. In human medicine, OSAS is diagnosed
in adult patients and anatomical abnormalities are not
the unique etiology of the syndrome. On the other hand,
BAOS is diagnosed in young brachycephalic patients
with upper airway abnormalities. Maybe those differ-
ences justify a less obvious systemic inflammatory re-
sponse in dogs suffering from BAOS. Actually, a clinical
grade system and upper airway examination can define
BAOS in canine patients. Even though, an objective clin-
ical test, such as apnea-hipopnea index, obtained during
polisomnography and used to define human OSAS se-
verity, could offer valuable information to better classify
and understand BAOS. On the other hand, the respira-
tory functional assessment using barometric whole-body
plethysmography in brachycephalic dogs could also be
used to characterize the respiratory compromise in those
dogs [5]. Due to the complexity of these tests, polisom-
nography and plethysmography were not available for
our study.
Several authors suggested that cTnI determination in
dogs is useful for identifying myocardial damage [38,39].
A large percentage of brachycephalic dogs (47.8%) had
high levels of cTnI. It is interesting to note that all
(100%) English bulldogs and 53.8% of French bulldog
had high levels of cTnI. The hypothesis is that, as occurs
in humans with OSAS, BAOS can induce surges in sym-
pathetic activity, hypoxia and increased blood pressure
that lead to myocardial damage.
All patients included in the study were submitted to a
thorough physical examination, blood work, thoracic x-
ray and an electrocardiogram, and no evidence of car-
diac disease was found. However brachycephalic dogs
may be predisposed to pulmonary hypertension, due to
chronic hypoxia, and dogs with pulmonary hypertension
can have increased concentrations of cTnI [40]. A limita-
tion of the study due to its multicentric nature is that
echocardiography was not performed in all dogs and
therefore pulmonary hypertension and occult cardiac
disease cannot be completely ruled out as a cause of in-
crease cTnI in some dogs from this study. Even though,
the evaluation of ECG (presence of arrhythmias and
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ated in relation to cTnI, CRP and Hp without obtaining
any association. Moreover cTnI levels can vary with age
and breed [38,41,42] and canine reference intervals must
be established for different age groups and breeds. This
information should be added to future studies. Although
further studies must clarify this condition, the results
obtained from this study suggest that some patients with
BAOS had hidden but biochemically detectable myocar-
dial injury. Even though, it must be considered that
repeated measurements of those biomarkers levels in
each individual dog could have increased the robustness
of the results. On the other hand, the lack of a control
group is an important limitation of the study since could
have helped to interpret the results. But it must be taken
to account, that is very difficult to find brachycephalic
dogs with a normal breathing pattern because nearly all
of them have some degree of upper airway obstruction.
Conclusions
To conclude, this study suggests that BAOS does not in-
duce an evident systemic inflammatory status according
to values of CRP and Hp. On the other hand, these pre-
liminary observations suggest that some dogs with
BAOS may suffer some grade of myocardial damage that
could be detected by cTnI levels. Further studies includ-
ing more animals are required to define the predictive
value of those biomarkers in dogs with BAOS. To the
authors’ knowledge, this is the first description of CRP,
Hp and cTnI levels in dogs with BAOS.
Methods
This multicentre study is based on a prospective evalu-
ation of brachycephalic dogs over a two-year period
(January 2008–January 2010) in four veterinary hospitals
(Hospital Clinic Veterinari, Barcelona; ARS Veterinaria,
Barcelona; Centro Policlínico Veterinario El Raspeig,
Alicante and Centre Hospitalier Vétérinaire Frégis,
Arcueil). The study group consisted of brachycephalic
dogs presented for the diagnosis of BAOS. In order to
be included in the study dogs must be brachycephalic
with clinical signs of upper airway obstruction, with a
body condition from 4/9 to 7/9, without any previous
treatment for BAOS and any present medication. On the
other hand, dogs included in the study must not present
any other illness apart from BAOS.
Ethical authority
The procedures conducted for this study were absolutely
designed to improve the welfare of dogs. Moreover, own-
ers were exhaustively informed of the blood work and
exploratory procedures applied on each animal, and
signed an authorization file of acceptance. On the other
hand, the study was evaluated and accepted by theEthical Committee on Animal and Human Research
(CEEAH) of the Universitat Autònoma de Barcelona
(UAB).
Clinical evaluation
Upon admission, a physical examination, thoracic radi-
ography and an electrocardiogram were performed on
all patients. Moreover cell blood count, serum biochem-
istry and serum levels of CRP, Hp and cTnI were evalu-
ated. A complete clinical form was obtained from each
patient, designed to homogenize the information be-
tween centers. The frequency of upper respiratory signs
(stertors, snoring, inspiratory effort, exercise intolerance
and syncope) and digestive signs (ptyalism, regurgitation
and vomiting) were recorded. On the basis of the fre-
quency of each respiratory and digestive sign, a global clas-
sification of four grades was obtained: absent (grade 0),
mild (grade 1), moderate (grade 2) and severe (grade 3).
Diagnosis of all anatomical components of BAOS was
made via oropharyngeal and laryngeal examination and
thoracic radiographs in anesthetized dogs. Premedication
included 0.05 mg/kg acepromacine and 0.01 mg/kg
buprenorfine intramuscularly. Anaesthesia was induced
with propofol. A soft palate that extended beyond its
contact with the epiglottis, or that extended caudally to
distal poles of the tonsils, was considered redundant.
BAOS diagnosis was carried out on the basis of both
upper airway respiratory signs and anatomic abnormal-
ities, as has been described elsewhere [25].
Lateral thoracic radiography aimed at measuring the
vertebral heart score and ratio of the thoracic inlet
(DTI) to the tracheal diameter (DT) was performed
anesthetized animals in order to detect tracheal hypopla-
sia, defined as DTI/DT ratio < 0.16 [22,34]. The findings
of physical examinations, cardiac auscultation, electro-
cardiographic and radiographic abnormalities, and blood
tests provided no evidence of any other diseases in
patients included in the study.
Biomarker analysis
Blood samples were collected in 5 mL serum blood
tubes and centrifuged within 30 minutes after collection.
The serum obtained was separated and stored at -80 °C
for biomarker analysis. Sample storage varied from 1 to
2 months. Samples were sent using dry ice and were
thawed only once, at the time of analysis.
CRP concentration was measured using a human
immunoturbidimetric assaya that showed a correlation
of 0.98 with a specific canine ELISA assayb which has
been validated for use in dogs [43]. A pooled canine
serum sample with high concentration of CRP measured
by the specific canine ELISA assay was used as standard.
Hp concentrations were measured by a commercially
available colorimetric methodc, previously validated in
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using an automated biochemistry analyzerd and had
intra-run and inter-run coefficients of variation < 10%.
cTnI was determined by the DPC Immulite, a previously
validated assay that gives satisfactory imprecision values
[19]. CRP, Hp and cTnI levels were classified as normal or
high according to our laboratory reference values (normal
values: CRP< 20 mg/L; Hp< 3 g/L; cTnI < 0.05 ng/ml).Statistical analysis
The statistical analysis was performed using the statis-
tical software SPSS statisticse. A value of p<0.05 was
used to determine significance. Data were tested for nor-
mality by Shapiro-Wilk and Kolmogorov-Smirnov tests.
Most data did not follow a normal distribution and non-
parametric tests were employed. A Spearman Rho test
(Table 2) was used to search for a correlation between
the degree of clinical signs and all the studied para-
meters. Two variables relating to the severity of clinical
signs were introduced into the database: grade of re-
spiratory signs and grade of digestive signs. Grades 1, 2
and 3 for respiratory signs were considered for analysis.
All grades were used for digestive signs. The Kruskall-
Wallis test was employed to compare values for a single
variable between three or more groups and differences
between groups were compared with rank sum (Mann–
Whitney U) tests.Endnotes
aCRP OSR 6147 Olympus Life and Material Science
Europe GmbH, Lismeehan, O’Callaghan’s Mills, Co. Clare,
Ireland
bTridelta Phase range canine CRP kit, Tridelta Devel-
opment Ltd, Brey, Ireland
cTridelta Phase range haptoglobin kit, Tridelta Devel-
opment Ltd.
dOlympus 2700 Automatic Chemistry Analyzer, Olym-
pus Europe GmbH, Hamburg, Germany
eSPSS 17.0 version, Chicago, IL, USA
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